Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Journal of Heart Failure|September 2, 2022
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trialOtavio Berwanger, Marc Pfeffer, Brian Claggett, et al.
European Journal of Heart Failure|December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial dataOffer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
European Journal of Heart Failure|November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trialMorten Schou, Brian Claggett, Zi Michael Miao, et al.
Circulation|November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI TrialRoxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
European Journal of Heart Failure|April 13, 2021
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristicsKarola S Jering, Brian Claggett, Marc A Pfeffer, et al.
European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.
The New England Journal of Medicine|November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial InfarctionMarc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Pageof 4